ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects

correlation with cardiac magnetic resonance and arrhythmogenesis.

David G. Strauss, Ronald H. Selvester, João A C Lima, Håkan Arheden, Julie M. Miller, Gary Gerstenblith, Eduardo Marbán, Robert G. Weiss, Gordon F. Tomaselli, Galen S. Wagner, Katherine C. Wu

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

BACKGROUND: Myocardial scarring from infarction or nonischemic fibrosis forms an arrhythmogenic substrate. The Selvester QRS score has been extensively validated for estimating myocardial infarction scar size in the absence of ECG confounders, but has not been tested to quantify scar in patients with hypertrophy, bundle branch/fascicular blocks, or nonischemic cardiomyopathy. We assessed the hypotheses that (1) QRS scores (modified for each ECG confounder) correctly identify and quantify scar in ischemic and nonischemic patients when compared with the reference standard of cardiac magnetic resonance using late-gadolinium enhancement, and (2) QRS-estimated scar size predicts inducible sustained monomorphic ventricular tachycardia during electrophysiological testing. METHODS AND RESULTS: One hundred sixty-two patients with left ventricular ejection fraction < or =35% (95 ischemic, 67 nonischemic) received 12-lead ECG and cardiac magnetic resonance using late-gadolinium enhancement before implantable cardioverter defibrillator placement for primary prevention of sudden cardiac death. QRS scores correctly diagnosed cardiovascular magnetic resonance scar presence with receiver operating characteristics area under the curve of 0.91 and correlation for scar quantification of r=0.74 (P<0.0001) for all patients. Performance within hypertrophy, conduction defect, and nonischemic subgroups ranged from area under the curve of 0.81 to 0.94 and r=0.60 to 0.80 (P<0.001 for all). Among the 137 patients undergoing electrophysiological or device testing, each 3-point QRS-score increase (9% left ventricular scarring) was associated with an odds ratio for inducing monomorphic ventricular tachycardia of 2.2 (95% CI, 1.5 to 3.2; P<0.001) for all patients, 1.7 (1.0 to 2.7, P=0.04) for ischemics, and 2.2 (1.0 to 5.0, P=0.05) for nonischemics. CONCLUSIONS: QRS scores identify and quantify scar in ischemic and nonischemic cardiomyopathy patients despite ECG confounders. Higher QRS-estimated scar size is associated with increased arrhythmogenesis and warrants further study as a risk-stratifying tool.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalCirculation. Arrhythmia and electrophysiology
Volume1
Issue number5
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Cardiomyopathies
Cicatrix
Electrocardiography
Magnetic Resonance Spectroscopy
Bundle-Branch Block
Gadolinium
Ventricular Tachycardia
Hypertrophy
Area Under Curve
Myocardial Infarction
Implantable Defibrillators
Sudden Cardiac Death
Primary Prevention
ROC Curve
Stroke Volume
Fibrosis
Odds Ratio
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects : correlation with cardiac magnetic resonance and arrhythmogenesis. / Strauss, David G.; Selvester, Ronald H.; Lima, João A C; Arheden, Håkan; Miller, Julie M.; Gerstenblith, Gary; Marbán, Eduardo; Weiss, Robert G.; Tomaselli, Gordon F.; Wagner, Galen S.; Wu, Katherine C.

In: Circulation. Arrhythmia and electrophysiology, Vol. 1, No. 5, 01.12.2008, p. 327-336.

Research output: Contribution to journalArticle

Strauss, David G. ; Selvester, Ronald H. ; Lima, João A C ; Arheden, Håkan ; Miller, Julie M. ; Gerstenblith, Gary ; Marbán, Eduardo ; Weiss, Robert G. ; Tomaselli, Gordon F. ; Wagner, Galen S. ; Wu, Katherine C. / ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects : correlation with cardiac magnetic resonance and arrhythmogenesis. In: Circulation. Arrhythmia and electrophysiology. 2008 ; Vol. 1, No. 5. pp. 327-336.
@article{8c43c71de0e7477abee213995762c521,
title = "ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.",
abstract = "BACKGROUND: Myocardial scarring from infarction or nonischemic fibrosis forms an arrhythmogenic substrate. The Selvester QRS score has been extensively validated for estimating myocardial infarction scar size in the absence of ECG confounders, but has not been tested to quantify scar in patients with hypertrophy, bundle branch/fascicular blocks, or nonischemic cardiomyopathy. We assessed the hypotheses that (1) QRS scores (modified for each ECG confounder) correctly identify and quantify scar in ischemic and nonischemic patients when compared with the reference standard of cardiac magnetic resonance using late-gadolinium enhancement, and (2) QRS-estimated scar size predicts inducible sustained monomorphic ventricular tachycardia during electrophysiological testing. METHODS AND RESULTS: One hundred sixty-two patients with left ventricular ejection fraction < or =35{\%} (95 ischemic, 67 nonischemic) received 12-lead ECG and cardiac magnetic resonance using late-gadolinium enhancement before implantable cardioverter defibrillator placement for primary prevention of sudden cardiac death. QRS scores correctly diagnosed cardiovascular magnetic resonance scar presence with receiver operating characteristics area under the curve of 0.91 and correlation for scar quantification of r=0.74 (P<0.0001) for all patients. Performance within hypertrophy, conduction defect, and nonischemic subgroups ranged from area under the curve of 0.81 to 0.94 and r=0.60 to 0.80 (P<0.001 for all). Among the 137 patients undergoing electrophysiological or device testing, each 3-point QRS-score increase (9{\%} left ventricular scarring) was associated with an odds ratio for inducing monomorphic ventricular tachycardia of 2.2 (95{\%} CI, 1.5 to 3.2; P<0.001) for all patients, 1.7 (1.0 to 2.7, P=0.04) for ischemics, and 2.2 (1.0 to 5.0, P=0.05) for nonischemics. CONCLUSIONS: QRS scores identify and quantify scar in ischemic and nonischemic cardiomyopathy patients despite ECG confounders. Higher QRS-estimated scar size is associated with increased arrhythmogenesis and warrants further study as a risk-stratifying tool.",
author = "Strauss, {David G.} and Selvester, {Ronald H.} and Lima, {Jo{\~a}o A C} and H{\aa}kan Arheden and Miller, {Julie M.} and Gary Gerstenblith and Eduardo Marb{\'a}n and Weiss, {Robert G.} and Tomaselli, {Gordon F.} and Wagner, {Galen S.} and Wu, {Katherine C.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1161/CIRCEP.108.798660",
language = "English (US)",
volume = "1",
pages = "327--336",
journal = "Circulation: Arrhythmia and Electrophysiology",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects

T2 - correlation with cardiac magnetic resonance and arrhythmogenesis.

AU - Strauss, David G.

AU - Selvester, Ronald H.

AU - Lima, João A C

AU - Arheden, Håkan

AU - Miller, Julie M.

AU - Gerstenblith, Gary

AU - Marbán, Eduardo

AU - Weiss, Robert G.

AU - Tomaselli, Gordon F.

AU - Wagner, Galen S.

AU - Wu, Katherine C.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - BACKGROUND: Myocardial scarring from infarction or nonischemic fibrosis forms an arrhythmogenic substrate. The Selvester QRS score has been extensively validated for estimating myocardial infarction scar size in the absence of ECG confounders, but has not been tested to quantify scar in patients with hypertrophy, bundle branch/fascicular blocks, or nonischemic cardiomyopathy. We assessed the hypotheses that (1) QRS scores (modified for each ECG confounder) correctly identify and quantify scar in ischemic and nonischemic patients when compared with the reference standard of cardiac magnetic resonance using late-gadolinium enhancement, and (2) QRS-estimated scar size predicts inducible sustained monomorphic ventricular tachycardia during electrophysiological testing. METHODS AND RESULTS: One hundred sixty-two patients with left ventricular ejection fraction < or =35% (95 ischemic, 67 nonischemic) received 12-lead ECG and cardiac magnetic resonance using late-gadolinium enhancement before implantable cardioverter defibrillator placement for primary prevention of sudden cardiac death. QRS scores correctly diagnosed cardiovascular magnetic resonance scar presence with receiver operating characteristics area under the curve of 0.91 and correlation for scar quantification of r=0.74 (P<0.0001) for all patients. Performance within hypertrophy, conduction defect, and nonischemic subgroups ranged from area under the curve of 0.81 to 0.94 and r=0.60 to 0.80 (P<0.001 for all). Among the 137 patients undergoing electrophysiological or device testing, each 3-point QRS-score increase (9% left ventricular scarring) was associated with an odds ratio for inducing monomorphic ventricular tachycardia of 2.2 (95% CI, 1.5 to 3.2; P<0.001) for all patients, 1.7 (1.0 to 2.7, P=0.04) for ischemics, and 2.2 (1.0 to 5.0, P=0.05) for nonischemics. CONCLUSIONS: QRS scores identify and quantify scar in ischemic and nonischemic cardiomyopathy patients despite ECG confounders. Higher QRS-estimated scar size is associated with increased arrhythmogenesis and warrants further study as a risk-stratifying tool.

AB - BACKGROUND: Myocardial scarring from infarction or nonischemic fibrosis forms an arrhythmogenic substrate. The Selvester QRS score has been extensively validated for estimating myocardial infarction scar size in the absence of ECG confounders, but has not been tested to quantify scar in patients with hypertrophy, bundle branch/fascicular blocks, or nonischemic cardiomyopathy. We assessed the hypotheses that (1) QRS scores (modified for each ECG confounder) correctly identify and quantify scar in ischemic and nonischemic patients when compared with the reference standard of cardiac magnetic resonance using late-gadolinium enhancement, and (2) QRS-estimated scar size predicts inducible sustained monomorphic ventricular tachycardia during electrophysiological testing. METHODS AND RESULTS: One hundred sixty-two patients with left ventricular ejection fraction < or =35% (95 ischemic, 67 nonischemic) received 12-lead ECG and cardiac magnetic resonance using late-gadolinium enhancement before implantable cardioverter defibrillator placement for primary prevention of sudden cardiac death. QRS scores correctly diagnosed cardiovascular magnetic resonance scar presence with receiver operating characteristics area under the curve of 0.91 and correlation for scar quantification of r=0.74 (P<0.0001) for all patients. Performance within hypertrophy, conduction defect, and nonischemic subgroups ranged from area under the curve of 0.81 to 0.94 and r=0.60 to 0.80 (P<0.001 for all). Among the 137 patients undergoing electrophysiological or device testing, each 3-point QRS-score increase (9% left ventricular scarring) was associated with an odds ratio for inducing monomorphic ventricular tachycardia of 2.2 (95% CI, 1.5 to 3.2; P<0.001) for all patients, 1.7 (1.0 to 2.7, P=0.04) for ischemics, and 2.2 (1.0 to 5.0, P=0.05) for nonischemics. CONCLUSIONS: QRS scores identify and quantify scar in ischemic and nonischemic cardiomyopathy patients despite ECG confounders. Higher QRS-estimated scar size is associated with increased arrhythmogenesis and warrants further study as a risk-stratifying tool.

UR - http://www.scopus.com/inward/record.url?scp=60349089919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60349089919&partnerID=8YFLogxK

U2 - 10.1161/CIRCEP.108.798660

DO - 10.1161/CIRCEP.108.798660

M3 - Article

VL - 1

SP - 327

EP - 336

JO - Circulation: Arrhythmia and Electrophysiology

JF - Circulation: Arrhythmia and Electrophysiology

SN - 1941-3149

IS - 5

ER -